ADC Therapeutics SA announced results from the ongoing pivotal Phase 2 clinical trial of camidanlumab tesirine (Cami) in relapsed or refractory (r/r) Hodgkin lymphoma....
bluebird bio, Inc. announced the outcome of the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) discussion of...
Qpatch is a state-of-the-art wearable device for measuring individual ECG signal to obtain accurate cardiac arrhythmia diagnosis across many days. It allows ECG monitoring...
LumiraDx Limited, a next-generation point of care diagnostics company, announced that it has achieved CE Mark for the Amira System, its new testing system...
Evidence Partners Inc., a market leader in AI-enabled literature review automation software and creator of DistillerSR, announced a collaboration with Akra Team, a German-based...
